Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal Carcinoma

Author:

Zheng Shuo-Han12,Liu Song-Ran13,Wang Hai-Bo4,Wei Ying-Hong12,Li He12,Wang Guan-Nan15,Huang Zi-Lu12,Ding Shi-Rong12,Chen Chen12,Tao Ya-Lan12,Li Xiao-Hui6,Glorieux Christophe1,Huang Peng17,Wu Yang-Feng4,Xia Yun-Fei12

Affiliation:

1. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China

2. Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

3. Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China

4. Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China

5. Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China

6. Department of Hematology and Endocrinology, The PLA 74th Group Army Hospital, Guangzhou, China

7. Center for Cancer Metabolism and Intervention Research, Sun Yat-sen University Cancer Center, Guangzhou, China

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference41 articles.

1. Nasopharynx carcinoma: choice of treatment.;al-Sarraf;Int J Radiat Oncol Biol Phys,1995

2. Natural development of nasopharyngeal carcinoma and clinical types of late stage cases.;Xie;Tientsin Med J,1963

3. Radiotherapy-related typing in 842 patients in canton with nasopharyngeal carcinoma.;Li;Int J Radiat Oncol Biol Phys,2006

4. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma.;Zhang;N Engl J Med,2019

5. Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the Mayo Clinic Phase 2 Consortium (NCI-9742).;Ma;J Clin Oncol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3